Search results
Results from the WOW.Com Content Network
The drug policy of the Philippines is guided by the Comprehensive Dangerous Drugs Act of 2002 and is implemented by the Dangerous Drugs Board with its implementing arm, the Philippine Drug Enforcement Agency along with other member agencies. Aside from regulating and prohibiting the usage, sale, production of certain drugs, the 2002 law is ...
Party-list: Manuel Cabochan MAGDALO: Party-list: Leonardo Babasa Jr. PDP–Laban: Zamboanga del Sur: 2nd: Macnell M. Lusotan MARINO Party-list: Julienne Baronda NUP: Iloilo City: Lone: Members for the Minority Arnolfo Teves Jr. PDP–Laban: Negros Oriental: 3rd: Sergio Dagooc APEC: Party-list: Francisca Castro ACT TEACHERS: Party-list: Argel ...
Pages in category "Drugs in Malaysia" This category contains only the following page. This list may not reflect recent changes. D. Dangerous Drugs Act 1952
The Dangerous Drugs (Forfeiture of Property) Act 1988 (Malay: Akta Dadah Berbahaya (Perlucuthakan Harta) 1988), is a Malaysian laws which enacted to make provisions for offences in relation to property, and for the seizure and forfeiture of property, connected with activity related to offences under this Act, the Dangerous Drugs Act 1952, or any foreign law corresponding to these Acts or to ...
Diversion, abuse, and a relatively high rate of overdose deaths in comparison to other drugs of its group. This drug continues to be available in most of the world including the US, but under strict controls. Terfenadine (Seldane, Triludan) 1997–1998 France, South Africa, Oman, others, US Prolonged QT interval; ventricular tachycardia [2] [3]
Karyn Hascal, The Healing Place’s president and CEO, said she would never allow Suboxone in her treatment program because her 12-step curriculum is “a drug-free model. There’s kind of a conflict between drug-free and Suboxone.” For policymakers, denying addicts the best scientifically proven treatment carries no political cost.
For example, between 2010 and 2018, outputs of chemicals and their products in Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam, increased in value by nearly 40 per cent from US$132 billion to US$181 billion. [5] Examples of such precursors and drugs made with them are listed below.
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs , ranked by sales.